PAREXEL International Corporation - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for PAREXEL International Corporation Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

PAREXEL International Corporation. The Group's principal activities are to provide biopharmaceutical services. The Group operates in three business segments: Clinical Research Services; PAREXEL Consulting and Medical Communications Services and Perceptive Informatics Inc. Clinical Research Services Segment provide clinical trials management and biostatistics, data management and clinical pharmacology services. PAREXEL Consulting and Marketing Services Segment provide technical expertise in disciplines such as drug development, regulatory affairs and biopharmaceutical process and management consulting. Perceptive Segment provides information technology solutions designed to improve clients' product development processes. The Group operates in the United States, Europe, Africa, Asia and other foreign countries. On 14-Aug-2009, the Group acquired ClinPhone plc.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report